Funding for this research was provided by:
itmo cancer of aviesan
Received: 25 June 2021
Accepted: 14 October 2021
First Online: 5 November 2021
: Ethical approval was granted by Sud-Est I research ethics committee (Reference Number CPP 2018–90) on October 8th, 2018, and authorized by the French authorities (ANSM) on September 25th, 2018.The written informed consent of all participants was required prior to participation in the study. Participants will not be identified in any reports or publications.
: Not applicable.
: The authors have declared no conflicts of interest.